The FDA Safety Act significantly reforms FDA’s inadequate postmarket drug safety program, correcting structural and regulatory shortcomings that have contributed to the agency’s high-profile drug safety failures in recent years.
The FDA Safety Act significantly reforms FDA’s inadequate postmarket drug safety program, correcting structural and regulatory shortcomings that have contributed to the agency’s high-profile drug safety failures in recent years.